+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Therapy with nebulized beta2 agonists (procaterol) in asthmatic children: pulmonary function and plasma levels after inhalation



Therapy with nebulized beta2 agonists (procaterol) in asthmatic children: pulmonary function and plasma levels after inhalation



Arerugi 56(11): 1372-1377



Relationship between post administrative changes in plasma drug levels and bronchodilation remains unknown. In this study, we measured plasma levels of procaterol, a beta2-agonist, when being inhaled through nebulizers in children with bronchial asthma to examine relationship between improvement of pulmonary function and the plasma levels. Six asthmatic children with the mean age of 9.8 years, inhaled 0.3 ml of 0.01% procaterol solution through a nebulizer. We examined changes in pulmonary function and plasma procaterol levels before and after inhalation. Procaterol was detected in the plasma 2 minutes after inhalation when it already rose to the maximum level, and kept the steady until showing a decline in 30 minutes. The measured highest value was 87.8+/-45.1 pg/ml. FEV 1.0 remarkably increased 2 minutes after inhalation and was maintained until 60 minutes after inhalation. Other lung function parameters also improved. There was no significant change in the heart rate, but serum potassium concentrations significantly dropped in all patients 60 minutes after inhalation. Plasma procaterol levels promptly rose to the peak at 2 minutes after inhalation and decreased 30 minutes later. Improvement of pulmonary function started promptly at minutes after inhalation and it became a peak 60 minutes later.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056551537

Download citation: RISBibTeXText

PMID: 18059150


Related references

Bronchial hyperresponsiveness changes after 5 months of regular procaterol inhalation therapy in asthmatic children. Journal of Asthma 30(1): 37-43, 1993

Effects of procaterol on arterial blood gas and pulmonary function in asthmatic children. Arerugi 39(12): 1590-1597, 1990

Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysis. Drug Testing and Analysis 8(10): 1056-1064, 2016

Beta2 agonists and anticholinergics. Inhalation therapy in acute deterioriation of asthma and chronic obstructive pulmonary disease. Ugeskrift for Laeger 158(42): 5957-5962, 1996

Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children. Monaldi Archives for Chest Disease 67(1): 30-38, 2007

Asthmatic Attack Complicated with Takotsubo Cardiomyopathy after Frequent Inhalation of Inhaled Corticosteroids/Long-Acting Beta2-Adrenoceptor Agonists. Internal Medicine 55(12): 1615-1620, 2016

Agreement between tracheal auscultation and pulmonary function in methacholine bronchial inhalation challenge in asthmatic children. Anales Espanoles de Pediatria 56(4): 304-309, 2002

Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists. Respiratory Medicine 96(3): 155-162, 2002

Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol. Allergology International 62(1): 131-135, 2013

Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists. Annals of Human Biology 33(2): 135-141, 2006

Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms. Respiratory Medicine 100(6): 1072-1078, 2005

Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and ipratropium bromide. American Journal of Respiratory and Critical Care Medicine 149(1): 81-85, 1994

Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist. European Journal of Pharmacology 53(4): 351-358, 1979

The effect of polymorphisms of beta2 adrenoceptors on response to long-acting beta2 agonists in Iranian asthmatic patients. Iranian Journal of Allergy, Asthma, and Immunology 12(4): 383-390, 2014

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Annals of Allergy, Asthma & Immunology 86(6): 633-640, 2001